Cargando…
Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion
BACKGROUND: Waldenström macroglobulinemia (WM) is a rare, indolent B-cell lymphoma. Clinically, chromosome 6q deletion (6q del) including loss of the B lymphocyte-induced maturation protein 1 gene (BLIMP-1) is reported to be associated with poor prognosis. However, it remains unclear how the underly...
Autores principales: | Sekiguchi, Naohiro, Nomoto, Junko, Nagata, Akihisa, Kiyota, Masahiro, Fukuda, Ichiro, Yamada, Kazuaki, Takezako, Naoki, Kobayashi, Yukio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193339/ https://www.ncbi.nlm.nih.gov/pubmed/30402490 http://dx.doi.org/10.1155/2018/6728128 |
Ejemplares similares
-
Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent
por: Sekiguchi, Naohiro, et al.
Publicado: (2018) -
The Impact of Tirabrutinib Monotherapy for Bing-Neel Syndrome in Waldenström's Macroglobulinemia
por: Sekiguchi, Naohiro
Publicado: (2022) -
Extramedullary hematopoietic pleural effusion in Waldenström's macroglobulinemia
por: Ito, Kenichi, et al.
Publicado: (2023) -
MYD88 L265P Mutations Are Correlated with 6q Deletion in Korean Patients with Waldenström Macroglobulinemia
por: Kim, Jung-Ah, et al.
Publicado: (2014) -
Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation
por: Forgeard, Nathalie, et al.
Publicado: (2022)